Prostatic Neoplasms: all 6,484 studies
Page 58 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical RadiotherapyStatus unknownNCT00653848Phase 3
- Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate CancerCompletedNCT00653757Phase 1/2
- Use of Multiphoton Microscopy in the Diagnosis of CancerCompletedNCT00652210Phase 1
- Use of Organic Germanium or Placebo for the Prevention of Radiation Induced FatigueStatus unknownNCT00651417Phase 2
- Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate CancerTerminatedNCT00651326Phase 3
- Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate BrachytherapyCompletedNCT00651222
- A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate CancerCompletedNCT00644488Phase 1
- Casodex - Nolvadex CombinationCompletedNCT00637871Phase 2
- Sclerotherapy of Internal Spermatic Veins in Patients With Varicocele and Localized Prostate CancerCompletedNCT00637208Not applicable
- Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer PatientsCompletedNCT00636740Phase 2
- Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers (PSX-X04)CompletedNCT00636558Phase 1
- Casodex 150-mg Compassionate Use Trial for Subjects With Prostate CancerNo longer availableNCT00636259
- Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001CompletedNCT00636090
- Open Label Trial to Assess Iressa in Prostate Cancer PatientsCompletedNCT00635856Phase 2
- Bone Health Observational StudyCompletedNCT00632905
- Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the ProstateCompletedNCT00632138Phase 3
- Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate CancerCompletedNCT00631527Phase 1
- Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer PatientsTerminatedNCT00630799Phase 3
- Shared Decision Making for Prostate Cancer Screening: a Practice-Based Randomized Controlled TrialCompletedNCT00630188Not applicable
- Dissemination of Prostate Cancer Screening to PCP's in African American CommunitiesTerminatedNCT00629330Phase 4
- A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate CancerCompletedNCT00629057Phase 1
- Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT00627354Phase 2
- A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate CancerStatus unknownNCT00625430Phase 1
- Internet-Based Education for Prostate Cancer ScreeningCompletedNCT00623090Phase 3
- USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node MetastasesCompletedNCT00622973Phase 3
- Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate CancerWithdrawnNCT00621413
- Exercise Training Among Men With Prostate CancerWithdrawnNCT00620932Not applicable
- Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid TumorsCompletedNCT00620295Phase 1
- Study of Sorafenib and Docetaxel in Metastatic Prostate CancerCompletedNCT00619996Phase 2
- The Specific Role of Isoflavones in Reducing Prostate Cancer RiskCompletedNCT00617617Phase 2
- Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate CancerCompletedNCT00616291Phase 1
- Imaging of Prostate Cancer Using Two-dimensional MR Spectroscopy and Diffusion Tensor ImagingWithdrawnNCT00611065Not applicable
- Brassica Vegetables or Indole-3-Carbinol in Treating Patients With PSA Recurrence After Surgery for Prostate CancerCompletedNCT00607932Not applicable
- The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate CancerCompletedNCT00605488Not applicable
- High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam RadiotherapyCompletedNCT00604526Phase 1
- Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological CancerStatus unknownNCT00601406Not applicable
- A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate CancerCompletedNCT00600535Phase 1
- Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the ProstateWithdrawnNCT00598858Phase 2
- Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate CancerCompletedNCT00598312Phase 3
- Isoflavone in Prostate-specific Antigen Recurrent Prostate CancerCompletedNCT00596895Phase 2
- Patient Preference Survey for Radiation OncologistsCompletedNCT00595218Not applicable
- Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone TherapyTerminatedNCT00593853Phase 2
- Magnetic Resonance Imaging and Spectroscopy of the ProstateCompletedNCT00590993
- Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEXCompletedNCT00590213Phase 4
- Coping in African American Prostate Cancer SurvivorsCompletedNCT00589966Not applicable
- Magnetic Resonance Spectroscopic Imaging of the Prostate at 3 TeslaCompletedNCT00588679Not applicable
- Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate CancerTerminatedNCT00585416Phase 2
- Diet, Genetic Variation and Prostate Cancer Among African AmericansCompletedNCT00584792
- Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance.CompletedNCT00584532Phase 2/3
- Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate CancerCompletedNCT00582842
- Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate CancerTerminatedNCT00582582Phase 2
- MRI/MRSI in Risk Assessment of Prostate Cancer PatientsCompletedNCT00582543Not applicable
- Men Undergoing Radical ProstatectomyCompletedNCT00582530
- Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate CancerCompletedNCT00582140Phase 1
- Pain in Cancer SurvivorsCompletedNCT00581724
- Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black MenCompletedNCT00581672
- Molecular Urine Tests for Prostate CancerCompletedNCT00581516
- Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate CancerWithdrawnNCT00581503
- Assessing Depression in a Geriatric Cancer PopulationCompletedNCT00580476
- Germline Alterations of Tumor Susceptibility Genes in New York Cancer PatientsActive, not recruitingNCT00579514Not applicable
- Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate CancerCompletedNCT00579423Phase 2
- Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial CancersActive, not recruitingNCT00579163
- The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and OlderActive, not recruitingNCT00579072
- Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker DataCompletedNCT00578409
- Molecular Studies and Clinical Correlations in Human Prostatic DiseaseActive, not recruitingNCT00578240
- Testosterone in Castration-Resistant Prostate CancerWithdrawnNCT00577980Phase 2
- Assessment of the Functional Significance of Accessory Pudendal ArteriesCompletedNCT00577876Not applicable
- Prostate Biomarker StudyCompletedNCT00574899
- Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate CancerCompletedNCT00574769Phase 1/2
- Far Infrared Radiation Treatment for Prostate CancerStatus unknownNCT00573820Phase 1
- Treatment of Localized Prostate Cancer With High Intensity Focused Ultrasound Using the Sonablate® 500 System in CanadaStatus unknownNCT00573586Not applicable
- A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)CompletedNCT00571675Phase 2
- Safety Study of TAK-700 in Subjects With Prostate Cancer.CompletedNCT00569153Phase 1/2
- Phase II Study of ASP3550 in Patients With Prostate CancerCompletedNCT00568516Phase 2
- A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate CancerCompletedNCT00564928Phase 2
- AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin LymphomaCompletedNCT00562380Phase 1
- Effect of Lap-Band Induced Weight Loss on Serum PSA LevelsWithdrawnNCT00562341
- Quality of Life Study for Prostate Cancer PatientsStatus unknownNCT00561444
- High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate CancerCompletedNCT00561314Phase 2
- High-Intensity Focused Ultrasound Therapy in Treating Patients With Localized Prostate CancerCompletedNCT00561262Phase 2
- Efficacy Study of ABR-215050 to Treat Prostate CancerCompletedNCT00560482Phase 2
- Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation TherapyWithdrawnNCT00559481Not applicable
- Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate CancerCompletedNCT00559429Phase 1
- A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate CancerCompletedNCT00557037Phase 2
- Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone TherapyCompletedNCT00554918Phase 2
- Open Label,Phase II Trial of MAB Dose Escalation OF Bicalutamide For Biochemical Failure In Prostate Cancer Patients.CompletedNCT00554086Phase 2
- Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate CancerCompletedNCT00553878Phase 2/3
- Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate CancerCompletedNCT00551044Not applicable
- Sutent Maintenance After Response to TaxotereStatus unknownNCT00550810Phase 2
- Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the ProstateCompletedNCT00548600Phase 3
- Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate CancerStatus unknownNCT00546039Phase 2
- Family Quality of Life Among Families With a Member Who is a Cancer PatientCompletedNCT00544336
- PCMRI - an MRI/TRUS System for the Evaluation of the ProstateStatus unknownNCT00542100Not applicable
- Evaluation of the Efficacy and Safety of Common Sage in Controlling Hot Flashes in Prostate Cancer Patients Treated by Androgen DeprivationCompletedNCT00541788Phase 1
- Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic CancerCompletedNCT00541281Phase 2
- RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local SurgeryCompletedNCT00541047Phase 3
- Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP TrialCompletedNCT00540059
- Radioimmunotherapy in Prostate Cancer Using 177Lu-J591 AntibodyCompletedNCT00538668Phase 1
- Investigational Study For the Treatment of Localized (T1c/T2a) Prostate Cancer With High Intensity Focused Ultrasound (HIFU) Using the Sonablate 500 (SB-500) System in CanadaWithdrawnNCT00537849Not applicable
- Changes in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Prostate CancerCompletedNCT00536653Not applicable